drug
as of 2026-07-01TMS targeted on the cerebellum
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by University Hospital, Strasbourg, France
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
DEVICE
Indications
Investigational (via trials)
Trials
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication